|
ADHD Across the Ages: Diagnostic and Treatment Implications. Episode 2: The Evolution of ADHD
Overview: In this podcast series, comprised of three stand-alone episodes (also available as webcasts), Drs. Andrew Cutler and Peter Jensen discuss the effect that age has on the clinical presentation of ADHD and what that means in terms of treatment selection and overall patient care. Episode 2 addresses evolving management strategies for patients with ADHD as they progress from childhood to adulthood.
Statement of Need: The following unmet needs regarding ADHD were revealed following a critical analysis of activity feedback, expert faculty assessment, and literature review:
- ADHD is a chronic disorder that (1) does not necessarily fade away with time, (2) can remain undiagnosed until adulthood, or (3) can start in adulthood. Appropriate understanding of symptom evolution is required to make a proper diagnosis at any age.
- Patients with ADHD have comorbid psychiatric disorders as well as weight issues, all of which can have an important impact on treatment selection.
- The different rating scales available to aid diagnosis and tracking of symptoms of ADHD may not be used as often as they should be.
- A number of new formulations of current ADHD medications are being tested and integrated into the market; these, in conjunction to patient education and therapy, may help improve treatment adherence.
To help fill these unmet needs, quality improvement efforts need to (1) provide education regarding the evolving symptom presentation of ADHD in childhood versus adulthood, (2) provide education on how to recognize and treat comorbid disorders in ADHD, (3) provide information on the different rating scales that can be used for ADHD, and (4) provide concise information about novel formulations of current and future ADHD medications and discuss the role of therapy in ADHD and how it can enhance adherence.
Learning Objectives: After completing this activity, participants should be better able to:
- Identify common symptom manifestations of ADHD at different ages
- Monitor and modify management strategies to address evolving symptoms and life situations
Target Audience: This CME activity has been developed for prescribers specializing in psychiatry. There are no prerequisites for this activity. Health care providers in all specialties who are interested in psychopharmacology, especially primary care physicians, nurses, psychologists, and pharmacists, are welcome for advanced study.
Accreditation Statement: The Neuroscience Education Institute is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Information on CME Credit: The Neuroscience Education Institute designates this educational activity for a maximum of 0.5 AMA PRA Category 1 CreditsTM. Physicians should only claim credit commensurate with the extent of their participation in the activity. Also available is a certificate of participation for completing this activity.
Please note: the content of this podcast activity is also presented as a webcast. If you received CME credit for that activity, you will not be able to receive credit again for completing this podcast activity.
Activity Instructions: This CME activity is in the form of an MP3/Podcast. You are advised to listen to it from beginning to end, evaluate the content presented, and then complete the posttest and activity evaluation. There is no fee for this activity. The estimated time for completion of this activity is 30 minutes.
Instructions for CME Credit: To receive a certificate of CME credit or participation, please complete the posttest and evaluation available only online at www.neiglobal.com/cme. If a score of 70% or more is attained, you will be able to immediately print your certificate. If you have CME-related questions, please call 888-535-5600, or email customerservice@neiglobal.com.
NEI Disclosure Policy: It is the policy of the Neuroscience Education Institute to ensure balance, independence, objectivity, and scientific rigor in all its educational activities. Therefore, all individuals in a position to influence or control content development are required by NEI to disclose any financial relationships or apparent conflicts of interest. Although potential conflicts of interest are identified and resolved prior to the activity being presented, it remains for the participant to determine whether outside interests reflect a possible bias in either the exposition or the conclusions presented.
These materials have been peer-reviewed to ensure the scientific accuracy and medical relevance of information presented and its independence from commercial bias. The Neuroscience Education Institute takes responsibility for the content, quality, and scientific integrity of this CME activity.
Individual Disclosure Statements: Full disclosures for all persons in a position to influence the content of this podcast are presented at the beginning of the podcast.
Disclosed financial relationships have been reviewed by the Neuroscience Education Institute CME Advisory Board to resolve any potential conflicts of interest. All faculty and planning committee members have attested that their financial relationships do not affect their ability to present well-balanced, evidence-based content for this activity.
Disclosure of Off-Label Use: This educational activity may include discussion of products or devices that are not currently labeled for such use by the FDA. Please consult the product prescribing information for full disclosure of labeled uses.
Disclaimer:The information presented in this educational activity is not meant to define a standard of care, nor is it intended to dictate an exclusive course of patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this educational activity should not be used by clinicians without full evaluation of their patients’ conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Primary references and full prescribing information should be consulted.
Participants have an implied responsibility to use the newly acquired information from this activity to enhance patient outcomes and their own professional development. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.
Cultural and Linguistic Competency: A variety of resources addressing cultural and linguistic competency can be found in this linked handout.
| Sponsor: This activity is sponsored by Neuroscience Education Institute. |
 |
| Support: This activity is supported by an educational grant from Shire Pharmaceuticals Inc. |
|
Date of Release/Expiration:
Release Date: November, 2009 CME Credit Expiration Date: October, 2012
System Requirements:
• Feed/media reader such as iTunes or Juice (free downloads)
• High speed Internet connection (e.g., Cable, DSL, or equivalent)
• Speakers connected to your computer and turned up
Use the link below to subscribe (free) to NEI's Sages of Psychopharmacology podcast, which includes this activity.
A podcast is a series of media files, such as audio or video, distributed over the Internet via a "web feed" for playback on portable media players (commonly MP3 players) and computers. A benefit of subscribing to a podcast is that as new podcast files are added to the series, they will automatically be downloaded for you.
|